Fortress Biotech, Inc.

News / Events

Latest News

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology

View Press Release View All News

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
Sign up today